Over-the-Counter Monograph User Fee Act (OMUFA)
GPTKB entity
Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:administeredBy |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:appliesTo |
over-the-counter drug manufacturers
|
| gptkbp:dateEnacted |
2020
|
| gptkbp:enables |
timely review of OTC monograph submissions
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:establishes |
user fee program for OTC monograph drugs
|
| gptkbp:firstFeeCollectionYear |
2021
|
| gptkbp:fundedBy |
FDA activities related to OTC monograph drugs
|
| https://www.w3.org/2000/01/rdf-schema#label |
Over-the-Counter Monograph User Fee Act (OMUFA)
|
| gptkbp:partOf |
Coronavirus Aid, Relief, and Economic Security Act (CARES Act)
|
| gptkbp:purpose |
to authorize FDA to collect user fees from manufacturers of over-the-counter drugs
|
| gptkbp:regulates |
over-the-counter monograph drugs
|
| gptkbp:renewalPeriod |
5 years
|
| gptkbp:shortName |
OMUFA
|
| gptkbp:bfsParent |
gptkb:OTC_monograph
|
| gptkbp:bfsLayer |
6
|